Serum homocysteine and folate levels in korean schizophrenic patients

Psychiatry Investigation

Volumn 8, Issue 2, 2011, Pages 134-140

  Kim, Tae Ho ^a   Moon, Seok Woo ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Folate; Homocysteine; References; Schizophrenia

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; FOLIC ACID BLOOD LEVEL; HOMOCYSTEINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROTOXICITY; ONSET AGE; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHIZOPHRENIA; SOUTH KOREA; VITAMIN BLOOD LEVEL;

EID: 79960953199     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2011.8.2.134     Document Type: Article

References (29)

1. Petronijević ND, Radonjić NV, Ivković MD, Marinković D, Piperski VD, Duricić BM, et al. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1921-1926.
2. Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism. Psychiatry Res 2010; 175:47-53.
3. Furie KL, Kelly PJ. Homocyst(e)ine and stroke. Semin Neurol 2006;26: 24-32.
4. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzh-eimer's disease. N Engl J Med 2002;346:476-483.
5. Kim JM, Kim SW, Shin IS, Yang SJ, Park WY, Kim SJ, et al. Folate, vitamin b(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 2008;5:36-40.
6. O'Suilleabhain PE, Oberie R, Bartis C, Dewey RB Jr, Bottiglieri T, Diaz-Arrastia R. Clinical course in Parkinson's disease with elevated homocysteine. Parkinsonism Relat Disord 2006;12:103-107.
7. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker Rh. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 2002;159:1790-1792.
8. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001; 81:645-672.
9. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000;20: 6920-6926.
10. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayadu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997;94:5923-5928.
11. Levine J, Stahl Z, Sela BA, Ruderman V, Shumaico O, Babushkin I, et al. Homocysteine-reducing strategies improve symptoms in chronic schi-zophrenic patients with hyperhomocysteinemia. Biol Psychiatry 2006; 60:265-269.
12. Freeman JM, Finkelstein JD, Mudd SH. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5, 10-methylenetetrahydrofolate reductase activity. N Engl J Med 1975;292: 491-496.
13. Regland B, Johansson BV, Gottfries CG. Homocysteinemia and schizophrenia as a case of methylation dificiency. J Neural Transm Gen Sect 1994;98:143-152.
14. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in me-thylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
15. Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, et al. Association between the methylenetetrahydrofolate reductase 677C → T missense mutation and schizophrenia. Mol Psychiatry 2000;5:323-326.
16. García-Miss Mdel R, Pérez-Mutul J, López-Canul B, Solís-Rodríguez F, Puga-Machado L, Oxté-Cabrera A, et al. Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia. J Psychiatr Res 2010;44:441-446.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Press; 1994.
18. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-270.
19. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J. Schizoph-renia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 1998;44:141-143.
20. Virgos C, Martorell L, Simó JM, Valero J, Figuera L, Joven J, et al. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport 1999; 10:2035-2038.
21. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayadu PV, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997;94: 5923-5928.
22. Spiro HR, Schimke RN, Welch JP. Schizophrenia in a patient with a defect in methionine metabolism. J Nerv Ment Dis 1965;141:285-290.
23. Cohen SM, Nichols A, Wyatt R, Pollin W. The administration of methionine to schizophrenic patients: a review of ten studies. Biol Psychiatry 1974;8:209-225.
24. Brune GG, Himwich HE. Effects of methionine loading on behavior of schizophrenic patients. J Nerv Ment Dis 1962;134:447-450.
25. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Tr-ansm Gen Sect 1995;100:165-169.
26. Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J. Metylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 1994;57:765-766.
27. Mudd SH, Freeman JM. N-5,10-methylenetetrahydrofolate reductase deficiency and schizophrenia: a working hypothesis. J Psychiatr Res 1974; 11:259-262.
28. Regland B, Germgård T, Gottfries CG, Grenfeldt B, Koch-Schmidt AC. Homozygous thermolabile metylenetetrahydrofolate reductase in schi-zophrenia-like psychosis. J Neural Transm 1997;104:931-941.
29. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J. Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 1998;44:141-143.